Transcriptional Alterations of ET-1 Axis and DNA Damage in Lung Tissue of a Rat Obesity Model
Abstract
Obesity has been implicated in the development of many cancers. This can lead to genome damage, especially in the form of double-strand break, the presence of which is now easily detected through nuclear phosphorylation of histone H2AX (γ-H2AX) focus assay. Recently, the endothelin (ET) axis has also been shown to have a role in the growth and progression of several tumors, including lung cancer. The aim of this study was to evaluate the ET-1 system transcriptional alterations and γ-H2AX in lung tissue of Zucker rats subdivided into obese (O, n=22) and controls (CO, n=18) rats: under either fasting conditions (COfc-Ofc) or acute hyperglycemia (COAH-OAH). Significantly higher prepro-ET-1 (p=0.05) and ET-converting enzyme (ECE)-2 mRNA expression was observed in O with respect to CO. A significant positive association was observed between prepro-ET-1 and ET-A in the whole rat population (p=0.009) or in the obese group alone (p=0.007). The levels of γ-H2AX in O and in OAH rats were significantly higher (p=0.019) than in the corresponding CO and COAH rats (p=0.038). The study shows an inappropriate secretion of ET-1 in O animals with a parallel DNA damage in their lungs, providing novel mechanisms by which ET receptor antagonist may exert organ protection.
Get full access to this article
View all available purchase options and get full access to this article.
References
Ahme S.I., Thompson J., Coulson J.M., and Woll P. (2000). Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 22, 422–431.
Bagnato A., Salani D., Di Castro V., Wu-Wong J.R., Tecce R., Nicotra M.R., Venuti A., and Ntali P.G. (1999). Expression of endothelin 1 and endothelin-A receptor ovarian carcinoma evidence for an autocrine role in tumor growth. Cancer Res 59, 720–727.
Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Ziegerm K., Guldberg P., Sehested M., Nesland J.M., Lukasm C., Orntoft T., Lukas J., and Bartek J. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870.
Battistini B., Chailer P., D'Orleans-Juste P., Briere N., and Sirois P. (1993). Growth regulatory properties of endothelins. Peptides 14, 385–399.
Bhalla A., Haque S., Taylor I., Winslet M., and Loizidou M. (2009). Endothelin receptor antagonism and cancer. Eur J Clin Invest 39, 74–77.
Blanco D., Vicent S., Fraga M.F., Fernandez-Garcia I., Freire J., Lujambio A., Esteller M., Ortiz-de-Solorzano C., Pio R., Lecanda F., and Montuenga L.M. (2007). Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia 9, 840–852.
Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., and Wittwer C.T. (2009). The MIQE guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin Chem 55, 611–622.
Cabiati M., Belcastro E., Caselli C., Prescimone T., D'Amico A., Guzzardi M.A., Iozzo P., Giannessi D., and Del Ry S. (2014). Endothelin system mRNA variation in the heart of Zucker rats: evaluation of a possible balance with natriuretic peptides. Nutr Metab Cardiovasc Dis 24, 1166–1173.
Cabiati M., Raucci S., Caselli C., Guzzardi M.A., D'Amico A., Prescimone T., Giannessi D., and Del Ry S. (2012). Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model. J Molec Endocrinol 48, 251–260.
Cabiati M., Raucci S., Liistro T., Belcastro E., Prescimone T., Caselli C., Matteucci M., Iozzo P., Mattii L., Giannessi D., and Del Ry S. (2013). Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model. PLoS One 8, e72959.
Chen S., Feng B., George B., Chakrabarti R., Chen M., and Chakrabarti S. (2010). Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab 298, E127–E137.
Cozzi J., Anegon I., Braun V., Gross A.C., Merrouche C., and Cherifi Y. (2009). Pronuclear DNA injection for the production of transgenic rats. Methods Mol Biol 561, 73–88.
Elshourbagy N.A., Korman D.R., Wu H.L., Sylvester D.R., Lee J.A., Nuthalaganti P., Bergsma D.J., Kumar C.S., and Nambi P. (1993). Molecular characterisation and regulation of the human endothelin receptors. J Biol Chem 268, 3873–3879.
Geurts A.M., Cost G.J., Freyvert Y., Zeitler B., Miller J.C., Choi V.M., Jenkins S.S., Wood A., Cui X., Meng X., Vincent A., Lam S., Michalkiewicz M., Schilling R., Foeckler J., Kalloway S., Weiler H., Ménoret S., Anegon I., Davis G.D., Zhang L., Rebar E.J., Gregory P.D., Urnov F.D., Jacob H.J., and Buelow R. (2009). Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433.
Guiducci L., Liistro T., Burchielli S., Panetta D., Bonora D., Di Cecco P., Bucci M., Moehrs S., Del Guerra A., Salvadori P.A., and Iozzo P. (2011). Contribution of organ blood flow, intrinsic tissue clearance and glycemia to the regulation of glucose use in obese and type 2 diabetic rats: a PET study. Nutr Metab Cardiovasc Dis 21, 726–732.
Kajima K., and Nihei Z. (1995). Expression of endothelin 1 immunohistochemistry in breast cancer. Surg Oncol 4, 309–315.
Kopelman P.G. (2000). Obesity as a medical problem. Nature 404, 635–643.
Lavrador M.S., Abbes P.T., Escrivao M.A., and Taddei J.A. (2011). Cardiovascular risks in adolescents with different degrees of obesity. Arq Bras Cardiol 96, 205–211.
Nakamuta M., Ohashi M., Tabata S., Tanabe Y., Goto K., Naruse M., Hiroshige K., and Nawata H. (1993). High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am J Gastroenteral 88, 248–252.
Nathan C. (2008). Epidemic inflammation: pondering obesity. Mol Med 14, 485–492.
Nelson J.B., Chan-Tack K., Hedican S.P., Magnuson S.R., Opgenorth T.J., Bova G.S., and Simons J.W. (1996). Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56, 663–668.
Nuciforo P.G., Luise C., Capra M., Pelosi G., and d'Adda di Fagagna F. (2007). Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Carcinogenesis 28, 2082–2088.
Pollock D.M., Keith T.L., and Highsmith F. (1995). Endothelin receptors and calcium signalling. FASEB J 9, 1196–1204.
Redon C.E., Nakamura A.J., Martin O.A., Parekh P.R., Weyemi U.S., and Bonner W.M. (2011). Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker. Aging (Albany NY) 3, 168–174.
Renehan A.G., Tyson M., Egger M., Heller R.F., and Zwahlen M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–578.
Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. (1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273, 5858–5868.
Rosenkranz S.K., Townsend D.K., Steffens S.E., and Harms C.A. (2010). Effects of a high-fat meal on pulmonary function in healthy subjects. Eur J Appl Physiol 109, 499–506.
Rubany G.M., and Polokoff M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46, 325–415.
Scarpato R., Castagna S., Aliotta R., Azzarà A., Ghetti F., Filomeni E., Giovannini C., Pirillo C., Testi S., Lombardi S., and Tomei A. (2013). Kinetics of nuclear phosphorylation (γ-H2AX) in human lymphocytes treated in vitro with UVB, bleomycin and mitomycin C. Mutagenesis 28, 465–473.
Scarpato R., Verola C., Fabiani B., Bianchi V., Saggese G., and Federico G. (2011). Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the gamma-H2AX focus assay and micronucleus test. FASEB J 25, 685–693.
Scott H.A., Gibson P.G., Garg M.L., Pretto J.J., Morgan P.M., Callister R., and Wood L.G. (2012). Relationship between body composition, inflammation and lung function in overweight and obese asthma. Respir Res 13, 1–10.
Shankar A., Loizidou M., Aliev G., Fredericks S., Holt D., Boulos P.B., Burnstock G., and Taylor I. (1998). Raised endothelin 1 levels in patients with endorectal liver metastases. Br J Surg 85, 502–506.
Stapleton P.A., James M.E., Goodwill A.G., and Frisbee J.C. (2008). Obesity and vascular dysfunction. Pathophysiology 15, 79–89.
Sutherland E.R., Goleva E., King T.S., Lehman E., Stevens A., Jackson D.L.P., Stream A.R., Fahy J.V., and Leung D.Y.M. (2012). Cluster analysis of obesity and asthma phenotypes. PLoS One 7, e3663.
Wang Z., and Nakayama T. (2010). Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 535918.
Watters G.P., Smart D.J., Harvey J.S., and Austin C.A. (2009). H2AX phosphorylation as a genotoxicity endpoint. Mutat Res 679, 50–58.
Wu S., Hopfner L., McNeill R., Wilson T., and Gopalakrishnan V. (2000). Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res 45, 994–1000.
Information & Authors
Information
Published In
Copyright
Copyright 2015, Mary Ann Liebert, Inc.
History
Published in print: March 2015
Published online: 17 February 2015
Published ahead of print: 17 December 2014
Accepted: 17 November 2014
Revision received: 10 November 2014
Received: 29 September 2014
Topics
Authors
Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.